Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
PUT
Salesforce
CRM
$168B
| $8.08M | 0.01% |
+59,000
| New | +$8.12M |
|
|
KSU
1252
DELISTED
Kansas City Southern
KSU
| $8.05M | 0.01% |
84,377
+45,904
| +119% | +$4.66M |
|
|
AERI
1253
DELISTED
Aerie Pharmaceuticals
AERI
| $8.05M | 0.01% |
222,900
-135,055
| -38% | -$6.34M |
|
|
TRQ
1254
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $8.04M | 0.01% |
487,430
-285,254
| -37% | -$5.14M |
|
1255
Standard BioTools
LAB
$255M
| $8.04M | 0.01% |
932,996
+588,862
| +171% | +$4.59M |
|
1256
Columbia Sportswear
COLM
$3.02B
| $8.04M | 0.01% |
95,586
-85,149
| -47% | -$7.55M |
|
1257
iShares Core US Aggregate Bond ETF
AGG
$139B
| $8.04M | 0.01% |
75,463
+24,949
| +49% | +$2.62M |
|
1258
NVIDIA
NVDA
$5.16T
| $8.03M | 0.01% |
2,405,360
-14,003,200
| -85% | -$67M |
|
1259
Live Nation Entertainment
LYV
$43.5B
| $7.96M | 0.01% |
161,617
-52,918
| -25% | -$2.79M |
|
|
NVTR
1260
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $7.95M | 0.01% |
486,809
+215,101
| +79% | +$4.11M |
|
|
CBPX
1261
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $7.95M | 0.01% |
+312,174
| New | +$9.13M |
|
1262
Teledyne Technologies
TDY
$29.1B
| $7.94M | 0.01% |
38,338
+33,316
| +663% | +$7.29M |
|
1263
Kimco Realty
KIM
$16.1B
| $7.93M | 0.01% |
541,143
+386,889
| +251% | +$6.07M |
|
|
HABT
1264
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $7.89M | 0.01% |
751,372
+400,667
| +114% | +$5.38M |
|
|
RVNC
1265
DELISTED
Revance Therapeutics, Inc.
RVNC
| $7.88M | 0.01% |
391,549
-239,107
| -38% | -$5.27M |
|
|
SEMG
1266
DELISTED
SEMGROUP CORPORATION
SEMG
| $7.88M | 0.01% |
571,497
+495,683
| +654% | +$8.91M |
|
|
YMAB
1267
DELISTED
Y-mAbs Therapeutics
YMAB
| $7.87M | 0.01% |
386,919
+67,013
| +21% | +$1.54M |
|
1268
Central Pacific Financial
CPF
$969M
| $7.87M | 0.01% |
323,181
+39,258
| +14% | +$1.03M |
|
1269
T-Mobile US
TMUS
$195B
| $7.84M | 0.01% |
123,297
+18,893
| +18% | +$1.27M |
|
|
AZUL
1270
DELISTED
Azul
AZUL
| $7.83M | 0.01% |
282,950
+125,953
| +80% | +$3.07M |
|
|
ISCA
1271
DELISTED
International Speedway Corp
ISCA
| $7.83M | 0.01% |
178,472
+110,858
| +164% | +$4.47M |
|
|
FBC
1272
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $7.81M | 0.01% |
295,879
-313,510
| -51% | -$9.37M |
|
|
1273
CALL
Bristol-Myers Squibb
BMY
$139B
| $7.8M | 0.01% |
150,000
-50,000
| -25% | -$2.69M |
|
|
DNKN
1274
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $7.79M | 0.01% |
121,470
-18,279
| -13% | -$1.3M |
|
1275
FIVE9
FIVN
$2.41B
| $7.79M | 0.01% |
178,088
-346,593
| -66% | -$13.9M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.